Live Analyst Rating Changes 1515 upgrades, downgrades & price-target moves · freshest Wall Street data, updated daily View live feed →
Analyst Tracker/Sean Dodge
BMO
Sean Dodge
BMO Capital
Wall Street Analyst
★★☆☆☆
#2019
on 13Foresight · ranked by our own returns
50%
Success Rate
+4.7%
Average Return
15 of 30 calls profitable · -4.7% vs benchmark
📈 Across the calls we could measure, roughly 50% of Sean Dodge's ratings turned a profit when each position was held for 2 year — averaging +4.7% per rating. These figures are computed by 13Foresight from historical prices, not supplied by the analyst.

Rating Distribution

44 Buy 32 Hold 0 Sell
Sean's Stock Coverage 31 ratings · 2026-06-19
Company Date Position Consensus ⓘ Price Target ⓘ 2-Yr Return
VEEV
Veeva Systems
 Jun 03, 2026 HOLD Buy
+54.2% avg upside
36 analysts
$175.00
14.24% Upside
 -9.3%
ICLR
Icon
 May 29, 2026 BUY Strong Buy
+24.0% avg upside
25 analysts
$160.00
9.69% Upside
 +8.6%
PHR
Phreesia
 May 27, 2026 BUY Strong Buy
+82.2% avg upside
21 analysts
$14.00
49.34% Upside
 ·
BTSG
BrightSpring Health Services, Inc.
 May 21, 2026 BUY Strong Buy
-16.1% avg upside
18 analysts
$70.00
5.75% Upside
 +11.1%
AVAH
Aveanna Healthcare Holdings
 May 15, 2026 BUY Buy
+16.7% avg upside
17 analysts
$10.00
28.37% Upside
 -2.6%
DOCS
Doximity
 May 14, 2026 HOLD Buy
+61.4% avg upside
27 analysts
$20.00
2.15% Downside
 +14.8%
CERT
Certara
 May 12, 2026 HOLD Buy
+133.3% avg upside
21 analysts
$6.00
8.22% Upside
 +18.9%
EVH
Evolent Health
 May 08, 2026 BUY Strong Buy
+121.1% avg upside
19 analysts
$6.00
33.67% Upside
 +1.0%
OMDA
Omada Health, Inc.
 May 08, 2026 BUY Strong Buy
+32.0% avg upside
11 analysts
$20.00
13.48% Upside
 +17.9%
LFST
Lifestance Health Group
 May 08, 2026 BUY Strong Buy
+8.7% avg upside
14 analysts
$11.00
22.49% Upside
 +11.8%
PRVA
Privia Health Group
 May 08, 2026 BUY Strong Buy
+34.1% avg upside
26 analysts
$30.00
26.72% Upside
 -6.2%
IQV
IQVIA Holdings
 May 08, 2026 BUY Strong Buy
+34.3% avg upside
38 analysts
$210.00
25.08% Upside
 -0.2%
SHC
Sotera Health
 May 06, 2026 BUY Strong Buy
+30.3% avg upside
13 analysts
$20.00
26.48% Upside
 -0.2%
ADUS
Addus Homecare
 May 05, 2026 HOLD Strong Buy
+35.9% avg upside
18 analysts
$110.00
16.77% Upside
 -5.1%
TDOC
Teladoc
 Apr 29, 2026 HOLD Buy
+257.8% avg upside
37 analysts
$5.00
38.05% Downside
 +19.2%
WAY
Waystar Holding Corp.
 Apr 29, 2026 BUY Strong Buy
+106.0% avg upside
29 analysts
$30.00
62.34% Upside
 -27.1%
TBRG
TruBridge
 Apr 24, 2026 HOLD Hold
+14.4% avg upside
9 analysts
$26.25
0.68% Upside
 +0.4%
MEDP
Medpace Holdings
 Apr 24, 2026 HOLD Buy
-12.0% avg upside
16 analysts
$400.00
13.03% Downside
 +13.8%
HCSG
Healthcare Services
 Apr 23, 2026 HOLD Buy
+5.8% avg upside
12 analysts
$24.00
4.63% Upside
 -4.9%
HQY
Healthequity
 Apr 09, 2026 BUY Strong Buy
+33.4% avg upside
20 analysts
$105.00
23.18% Upside
 +1.7%
MDLN
Medline
 Feb 26, 2026 BUY Strong Buy
+42.9% avg upside
26 analysts
$54.00
50.20% Upside
 -26.5%
GDRX
GoodRx Holdings
 Feb 27, 2025 BUY Buy
+387.3% avg upside
28 analysts
$6.00
125.52% Upside
 -47.6%
HCAT
Health Catalyst
 Feb 26, 2025 HOLD Buy
+215.1% avg upside
15 analysts
$6.00
244.90% Upside
 -75.9%
AGL
Agilon Health
 Feb 25, 2025 BUY Buy
-59.1% avg upside
26 analysts
$3.50
96.92% Downside
 +25.4%
OPRX
OptimizeRx
 Jan 08, 2025 HOLD Strong Buy
+158.1% avg upside
9 analysts
$6.00
20.55% Upside
 -8.5%
MDRX
Veradigm
 Mar 13, 2024 BUY Buy
+207.0% avg upside
22 analysts
$11.00
129.26% Upside
 -39.9%
OTRKQ
Ontrak
 May 11, 2022 HOLD Buy
+21716566.7% avg upside
7 analysts
$2.00
1999900.09% Upside
 ·
NUVB
Nuvation Bio
 Nov 10, 2021 BUY Strong Buy
+132.2% avg upside
15 analysts
$16.00
187.72% Upside
 -85.2%
ACH
Accendra Health
 Feb 20, 2019 HOLD Hold
+439.4% avg upside
17 analysts
$7.00
116.76% Upside
 +301.2%
IBM
International Business Machines
 May 19, 2017 SELL Buy
+0.0% avg upside
40 analysts
$135.00
45.72% Downside
 +3.5%
MCK
McKesson
 Aug 02, 2010 BUY Strong Buy
-2.2% avg upside
27 analysts
 — +40.7%
🔒 26 more ratings — with price targets, crowd consensus and our measured returns.
Sign in free to unlock See Pro plans
Free account unlocks every analyst's full coverage table.
Sean Dodge — Frequently Asked Questions
How accurate are Sean Dodge's stock ratings?
Based on the calls 13Foresight could measure, about 50% of Sean's ratings were profitable over a one-year hold, with an average return of -3.9% per rating, or -9.5% versus the S&P 500. We score every analyst the same way, from historical prices.
How is Sean ranked on 13Foresight?
Sean Dodge is currently ranked #2019 with a 2-star rating. Our rank blends hit rate, average return versus the market, and how many calls we have to judge — so a long, consistent record outweighs a few lucky picks. It is our own calculation, updated daily.
Which stocks does Sean cover?
Sean most recently has ratings on VEEV, ICLR, PHR, BTSG, AVAH, DOCS, CERT, EVH, OMDA, LFST, PRVA, IQV and 19 more. See the full coverage table above for positions, price targets and our measured returns.
Where can I see other analyst ratings?
Browse the full analyst leaderboard to compare Wall Street analysts ranked by their measured performance, success rate and average return.

Disclaimer: 13Foresight compiles analyst ratings and price targets from publicly available sources. Performance metrics, rankings and star ratings shown here are calculated independently by 13Foresight from historical market prices and may differ from figures published elsewhere. This information may be incomplete, delayed or inaccurate, is provided for research and informational purposes only, and is not investment advice. The underlying ratings and opinions are those of the respective analysts and their firms; 13Foresight accepts no liability for any decisions made based on this data.